Free Trial

Protalix BioTherapeutics (PLX) News Today

Protalix BioTherapeutics logo
$1.69 +0.06 (+3.68%)
(As of 11/20/2024 ET)
PLX: Self-Sustaining Rise to Lead in Renal Rare Disease
Earnings Outlook For Protalix BioTherapeutics
Protalix BioTherapeutics Inc.
Protalix BioTherapeutics, Inc. stock logo
Protalix BioTherapeutics, Inc. to Post FY2024 Earnings of $0.06 Per Share, Zacks Small Cap Forecasts (NYSE:PLX)
Protalix BioTherapeutics, Inc. (NYSE:PLX - Free Report) - Investment analysts at Zacks Small Cap decreased their FY2024 earnings per share estimates for shares of Protalix BioTherapeutics in a research note issued to investors on Thursday, August 22nd. Zacks Small Cap analyst J. Vandermosten now
PLX: A Focus on Renal Rare Disease
PLX Sep 2024 7.500 call (PLX240920C00007500)
Protalix BioTherapeutics, Inc. stock logo
Protalix BioTherapeutics (NYSE:PLX) Releases Earnings Results, Misses Expectations By $0.05 EPS
Protalix BioTherapeutics (NYSE:PLX - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.05). The company had revenue of $13.47 million for the quarter, compared to analyst estimates of $12.50 million. Protalix BioTherapeutics had a return on equity of 19.48% and a net margin of 11.48%. During the same period in the previous year, the business posted ($0.07) EPS.
What Wall Street expects from Protalix BioTherapeutics's earnings
PLX Aug 2024 0.500 put (PLX240816P00000500)
Protalix BioTherapeutics, Inc. stock logo
Protalix BioTherapeutics (NYSE:PLX) Trading Down 7.1%
Protalix BioTherapeutics (NYSE:PLX) Stock Price Down 7.1%
Protalix BioTherapeutics, Inc. stock logo
Protalix BioTherapeutics (NYSE:PLX) Trading 0.4% Higher
Protalix BioTherapeutics (NYSE:PLX) Trading Up 0.4%
PLX: First Quarter Update
Protalix BioTherapeutics Inc. Q1 Loss Increases, Misses Estimates
Protalix BioTherapeutics, Inc. stock logo
Protalix BioTherapeutics (NYSE:PLX) Downgraded to "Hold" at StockNews.com
StockNews.com cut Protalix BioTherapeutics from a "buy" rating to a "hold" rating in a research note on Friday.
Production cuts, geopolitical tensions drive oil rally
PLX: Elfabrio Geographic Expansion
Earnings Preview: Protalix BioTherapeutics
Protalix BioTherapeutics, Inc. stock logo
Protalix BioTherapeutics (PLX) Scheduled to Post Quarterly Earnings on Thursday
Protalix BioTherapeutics (NYSE:PLX) will be releasing earnings on Thursday, March 14, Yahoo Finance reports.
Protalix Biotherapeutics, Inc.
Get Protalix BioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PLX and its competitors with MarketBeat's FREE daily newsletter.

Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.

PLX Media Mentions By Week

PLX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PLX
News Sentiment

0.01

0.45

Average
Medical
News Sentiment

PLX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PLX Articles
This Week

6

1

PLX Articles
Average Week

Get Protalix BioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PLX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:PLX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners